We are live on ! Find out more
TI

Telemetry Investments Portfolio holdings

AUM $63.3M
1-Year Est. Return 0.06%
This Fund
S&P 500
This Quarter Est. Return
-4.19%
1 Year Est. Return
+0.06%
3 Year Est. Return
+77.42%
5 Year Est. Return
+156.79%
10 Year Est. Return
AUM
$129M
AUM Growth
-$67.4M
Cap. Flow
-$60.9M
Cap. Flow %
-47.04%
Top 10 Hldgs %
62.88%
Holding
130
New
32
Increased
19
Reduced
25
Closed
48

Sector Composition

Rank Sector Weight
1 Healthcare 15.35%
2 Communication Services 3.27%
3 Materials 2.17%
4 Technology 1.98%
5 Industrials 1.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIRX
76
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$44K 0.03%
1,743
-3,902
-69% -$151K
GNW icon
77
Genworth Financial
GNW
$3.86B
$42K 0.03%
11,200
-2,800
-20% -$9.92K
ROSEW
78
DELISTED
Rosehill Resources Inc.
ROSEW
$29K 0.02%
61,260
-50,000
-45% -$24.5K
ADNT icon
79
Adient
ADNT
$1.69B
-12,253
Closed -$159K
AGI icon
80
Alamos Gold
AGI
$12B
-14,825
Closed -$75K
AMRN
81
CALL
Amarin Corp
AMRN
$297M
-1,000
Closed -$415K
BA icon
82
PUT
Boeing
BA
$169B
-5,000
Closed -$1.91M
BAC icon
83
CALL
Bank of America
BAC
$429B
-70,000
Closed -$1.93M
BMY icon
84
Bristol-Myers Squibb
BMY
$129B
-6,300
Closed -$301K
BOIL icon
85
ProShares Ultra Bloomberg Natural Gas
BOIL
$334M
-7
Closed -$265K
CRIS icon
86
Curis
CRIS
$9.71M
-66
Closed -$52K
CRNT icon
87
Ceragon Networks
CRNT
$188M
-53,069
Closed -$191K
CVS icon
88
CALL
CVS Health
CVS
$135B
-60,000
Closed -$3.24M
CVS icon
89
CVS Health
CVS
$135B
-4,000
Closed -$216K
ESPR
90
DELISTED
Esperion Therapeutics
ESPR
-7,500
Closed -$301K
FITB
91
Fifth Third Bancorp
FITB
$51.3B
-8,200
Closed -$207K
GM icon
92
CALL
General Motors
GM
$80.9B
-125,300
Closed -$4.65M
GRPN icon
93
Groupon
GRPN
$1.03B
-1,820
Closed -$129K
KPTI icon
94
CALL
Karyopharm Therapeutics
KPTI
$155M
-3,333
Closed -$292K
LLY icon
95
PUT
Eli Lilly
LLY
$1.08T
-30,000
Closed -$3.89M
META icon
96
PUT
Meta Platforms (Facebook)
META
$1.49T
-25,000
Closed -$4.17M
MPC icon
97
Marathon Petroleum
MPC
$90.1B
-4,797
Closed -$287K
MRNA icon
98
PUT
Moderna
MRNA
$21.6B
-30,000
Closed -$610K
MU icon
99
CALL
Micron Technology
MU
$835B
-50,000
Closed -$2.07M
NFLX icon
100
PUT
Netflix
NFLX
$307B
-60,000
Closed -$2.14M

Similar funds

Telemetry Investments's Q2 2019 Portfolio in Review

As of Q2 2019, Telemetry Investments held 130 positions worth $129M, down 34% from $197M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Telemetry Investments withdrew a net $60.9M in Q2 2019, closing 48 positions and reducing 25 holdings. Its most notable exit was Integrated Device Technology I, an estimated $2.41M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 10% a quarter earlier, followed by Communication Services and Materials.

Against the trend, Telemetry Investments opened a new position in Versum Materials, Inc. worth $2.12M.

  • Telemetry Investments's largest Q2 2019 buy was Versum Materials, Inc.: 41,000 shares worth $2.12M.
  • Telemetry Investments added most to Eiger BioPharmaceuticals, Inc. in Q2 2019, an estimated $2.7M increase.
  • Telemetry Investments's biggest Q2 2019 reduction was Rosehill Resources Inc. Class A, cutting an estimated $524K.
  • Telemetry Investments fully exited Integrated Device Technology I in Q2 2019, selling an estimated $2.41M.
  • Telemetry Investments's ten largest holdings make up 63% of its $129M portfolio in Q2 2019.
  • Telemetry Investments opened 32 new positions and closed 48 in Q2 2019.
  • Telemetry Investments's portfolio value fell 34% quarter-over-quarter to $129M.

Based on Telemetry Investments's 13F filing for Q2 2019, filed 14 Aug 2019.